Tanios Bekaii-Saab

Tanios Bekaii-Saab

UNVERIFIED PROFILE

Are you Tanios Bekaii-Saab?   Register this Author

Register author
Tanios Bekaii-Saab

Tanios Bekaii-Saab

Publications by authors named "Tanios Bekaii-Saab"

Are you Tanios Bekaii-Saab?   Register this Author

100Publications

2629Reads

11Profile Views

Antiangiogenic Therapy in Colorectal Cancer.

Cancer J 2018 Jul/Aug;24(4):165-170

Department of Hematology and Oncology, Mayo Clinic Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000328DOI Listing
June 2019

AJCC 8th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (iCCA): ready for prime time?

Chin Clin Oncol 2019 May 6. Epub 2019 May 6.

Department of Internal Medicine, Division of Hematology/Medical Oncology, Mayo Clinic, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.04.04DOI Listing
May 2019

Sister Mary Joseph's Nodule in Advanced Pancreatic Adenocarcinoma Identified on Hybrid F-FDG PET/MR.

J Nucl Med Technol 2019 Apr 24. Epub 2019 Apr 24.

Mayo Clinic Arizona, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnmt.119.225961DOI Listing
April 2019

Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.

Clin Colorectal Cancer 2019 03 16;18(1):e117-e129. Epub 2018 Nov 16.

Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2018.11.002DOI Listing
March 2019

Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies.

Biomedicines 2019 Mar 10;7(1). Epub 2019 Mar 10.

Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
https://www.mdpi.com/2227-9059/7/1/17
Publisher Site
http://dx.doi.org/10.3390/biomedicines7010017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466109PMC
March 2019

Watch and Wait in Rectal Cancer: Who's In and Who's Out?

J Oncol Pract 2019 Mar;15(3):133-134

1 Mayo Clinic Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00071DOI Listing
March 2019

Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.

Invest New Drugs 2018 12 22;36(6):1037-1043. Epub 2018 May 22.

Department of Medicine, Mayo Clinic, 5881 E Mayo Blvd, Phoenix, AZ, 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0600-2DOI Listing
December 2018

Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.

Small GTPases 2018 11 9;9(6):452-456. Epub 2016 Dec 9.

a Institute of Biological Chemistry , Academia Sinica , Taipei , Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21541248.2016.1251383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204986PMC
November 2018

Clinical update on K-Ras targeted therapy in gastrointestinal cancers.

Crit Rev Oncol Hematol 2018 Oct 2;130:78-91. Epub 2018 Aug 2.

Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.07.011DOI Listing
October 2018

A closer look at regorafenib.

Clin Adv Hematol Oncol 2018 Oct;16(10):667-669

Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
October 2018

Novel immunotherapy strategies for hepatobiliary cancers.

Immunotherapy 2018 09;10(12):1077-1091

Department of Medicine, Division of Hematology & Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2018-0024DOI Listing
September 2018

Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.

Clin Adv Hematol Oncol 2018 Sep;16 Suppl 17(9):1-16

Center for Carcinoid and Neuroendocrine Tumors, Mount Sinai School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
September 2018

A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma.

Clin Adv Hematol Oncol 2018 Sep;16 Suppl 17(9):5-7

Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
September 2018

New guideline-sanctioned and emerging interventions for pancreatic cancer.

Clin Adv Hematol Oncol 2018 Sep;16 Suppl 17(9):7-9

Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
September 2018

How I treat metastatic colorectal cancer.

Clin Adv Hematol Oncol 2018 Sep;16 Suppl 18(9):2-6

Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
September 2018

Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma.

Cancers (Basel) 2018 Jun 11;10(6). Epub 2018 Jun 11.

Department of Hematology/Medical Oncology, Mayo Clinic Cancer Center, 5777 E. Mayo Blvd, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10060193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025083PMC
June 2018

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer.

Int J Cancer 2018 04 17;142(8):1671-1675. Epub 2017 Nov 17.

Department of Internal Medicine, Mayo Clinic, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31144DOI Listing
April 2018

A clinical trial protocol paper discussing the BRIGHTER study.

Future Oncol 2018 Apr 3;14(10):901-906. Epub 2018 Jan 3.

Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0406DOI Listing
April 2018

Clinical Trials and Progress in Metastatic Colon Cancer.

Surg Oncol Clin N Am 2018 04;27(2):349-365

Gastrointestinal Cancer Program, Mayo Clinic Cancer Center, Mayo Clinic Arizona, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2017.11.008DOI Listing
April 2018

Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.

Future Oncol 2018 Mar 20;14(6):553-566. Epub 2018 Feb 20.

Division of Hematology Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0451DOI Listing
March 2018

Highlights in pancreatic cancer from the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium: commentary.

Clin Adv Hematol Oncol 2018 Mar;16 Suppl 7(3):16-18

Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
March 2018

A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer.

Oncologist 2018 01 11;23(1):25-34. Epub 2017 Oct 11.

Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic Cancer Center, Phoenix, Arizona, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759820PMC
January 2018

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

J Clin Oncol 2018 01 28;36(3):276-282. Epub 2017 Nov 28.

Milind Javle and Rachna T. Shroff, The University of Texas MD Anderson Cancer Center, Houston, TX; Maeve Lowery and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY; Karl Heinz Weiss and Christoph Springfeld, Universitäts Klinikum Heidelberg, Heidelberg, Germany; Mitesh J. Borad, Ramesh K. Ramanathan, and Tanios Bekaii-Saab, Mayo Clinic, Phoenix, AZ; Lipika Goyal and Andrew X. Zhu, Massachusetts General Hospital Cancer Center, Boston, MA; Saeed Sadeghi and Richard S. Finn, David Geffen School of Medicine at UCLA; Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles; Robin Kate Kelley, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Teresa Macarulla, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ivan Borbath, Cliniques Universitaires Saint-Luc, Brussels; Eric Van Cutsem, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium; Su Pin Choo, National Cancer Centre of Singapore, Singapore; Do-Youn Oh, Seoul National University, Seoul, South Korea; Philip A. Philip, Karmanos Cancer Institute, Detroit, MI; Li-Tzong Chen, National Institute of Cancer Research and National Cheng Kung University Hospital, Tainan; Kun-Huei Yeh, National Taiwan University Hospital Cancer Center, and Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan; Thanyanan Reungwetwattana, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Kristen Ciombor, The Ohio State University Wexner Medical Center, Columbus, OH; and Anuradha Patel, Suman Sen, Dale Porter, and Randi Isaacs, Novartis Pharmaceuticals Corporation, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075847PMC
January 2018

Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis.

Am J Clin Oncol 2017 Dec;40(6):569-573

Department of Hematology and Oncology, Winship Cancer Institute, Emory University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000210DOI Listing
December 2017

Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.

Cancer 2017 Dec 17;123(23):4680-4686. Epub 2017 Aug 17.

Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30927DOI Listing
December 2017

Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.

Cancer Treat Rev 2017 Nov 31;60:109-119. Epub 2017 Aug 31.

Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.08.006DOI Listing
November 2017

Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.

Pancreas 2017 10;46(9):1152-1157

From the *Division of Gastroenterology, Hepatology, and Nutrition, †Department of Radiology, ‡Division of Surgical Oncology, §Department of Cancer Biology and Genetics, ∥Division of Biostatistics, College of Public Health, ¶Division of General Surgery, #Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH; and **Division of Medical Oncology and Hematology, Mayo Clinic, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000898DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679236PMC
October 2017

Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer.

Diagnostics (Basel) 2017 Sep 2;7(3). Epub 2017 Sep 2.

Department of Radiology, Division of Vascular & Interventional Radiology, Mayo Clinic, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diagnostics7030050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617950PMC
September 2017

Response to Drs Von Hoff and Renschler.

Ther Adv Med Oncol 2017 Jun 30;9(6):445-446. Epub 2017 May 30.

Department of Medicine, Division of Hematology/Medical Oncology, Mayo Clinic, 5777 East Mayo Clinic Boulevard, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834017709238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455884PMC
June 2017

Signaling pathways as therapeutic targets in biliary tract cancer.

Expert Opin Ther Targets 2017 May 17;21(5):485-498. Epub 2017 Mar 17.

b Department of Hematology and Medical Oncology , The Winship Cancer Institute of Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2017.1306055DOI Listing
May 2017

Identifying and targeting cancer stem cells in the treatment of gastric cancer.

Cancer 2017 04 24;123(8):1303-1312. Epub 2017 Jan 24.

Department of Hematology and Medical Oncology, Emory School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412889PMC
April 2017

Therapeutic options for intrahepatic cholangiocarcinoma.

Hepatobiliary Surg Nutr 2017 Apr;6(2):91-100

Hematology/Medical Oncology, Mayo Clinic, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/hbsn.2016.12.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411274PMC
April 2017

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies.

Biomedicines 2017 Mar 4;5(1). Epub 2017 Mar 4.

Division of Hematology/Medical Oncology, Mayo Clinic, 5777 E. Mayo Blvd, Phoenix, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2227-9059/5/1/10
Publisher Site
http://dx.doi.org/10.3390/biomedicines5010010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423495PMC
March 2017

Outcomes of definitive chemoradiation in patients with esophageal cancer.

Dis Esophagus 2017 Feb;30(2):1-7

Mayo Clinic Cancer Center, Phoenix Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dote.12506DOI Listing
February 2017

Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease.

Mol Cancer Res 2017 01 2;15(1):26-34. Epub 2016 Nov 2.

Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-16-0200-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909689PMC
January 2017

Competitive Funding Strategies for the Conquer Cancer Foundation of ASCO.

J Oncol Pract 2017 01 22;13(1):e62-e67. Epub 2016 Nov 22.

Mayo Clinic, Phoenix, AZ; Albert Einstein College of Medicine, Bronx, NY; American Society of Clinical Oncology, Alexandria, VA; Aurora Health Care, Milwaukee, WI; and The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.014571DOI Listing
January 2017

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42.

Neoplasia 2016 Dec 25;18(12):765-774. Epub 2016 Nov 25.

Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, 1 University Rd., Tainan 701, Taiwan; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, 1 University Rd., Tainan 701, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126135PMC
December 2016

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.

J Natl Compr Canc Netw 2016 12;14(12):1528-1534

From Division of Surgical Oncology, The Ohio State University Wexner Medical Center/Arthur G. James Cancer Hospital, Columbus, Ohio; Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; City of Hope Comprehensive Cancer Center, Duarte, California; University of Texas MD Anderson Cancer Center, Houston, Texas; Kalispell Regional Healthcare Specialists, Kalispell Regional Healthcare, Kalispell, Montana; Memorial Sloan Kettering Cancer Center, New York, New York; Dana-Farber Cancer Institute, Boston, Massachusetts; and Depaartment of Medicine, Division of Hematology/Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292039PMC
http://dx.doi.org/10.6004/jnccn.2016.0164DOI Listing
December 2016

Taking aim at the genomic diversity of gastrointestinal cancers: a changing landscape.

J Gastrointest Oncol 2016 Oct;7(5):673-674

Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2016.09.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056257PMC
October 2016

Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses.

Genet Med 2016 09 11;18(9):863-8. Epub 2016 Feb 11.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2015.184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489337PMC
September 2016

Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine.

Clin Colorectal Cancer 2016 Sep 20. Epub 2016 Sep 20.

Department of Pharmacy, The James Comprehensive Cancer Center at The Ohio State University, Columbus, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2016.09.004DOI Listing
September 2016

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair.

J Natl Cancer Inst 2016 Jul 4;108(7). Epub 2016 Feb 4.

Divisions of Medical Oncology (MAVC, WD, JR, ML, TBS) and Clinical Cancer Genetics (JAW), Department of Pathology (WZ, KS), Comprehensive Cancer Center (MAVC, WD, LJS, JT, TBS, CT), and Center for Biostatistics (LX), The Ohio State University , Columbus, OH ; Lombardi Cancer Center, Georgetown University , Washington, DC (JM); National Cancer Institute , Bethesda, MD (JJ, AC).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/7/djv437.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv43
Publisher Site
http://dx.doi.org/10.1093/jnci/djv437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948564PMC
July 2016

Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity.

Ann Surg Oncol 2016 07 10;23(7):2281-6. Epub 2016 Mar 10.

Division of Surgical Oncology, The Ohio State University Wexner Medical Center, M256 Starling Loving Hall, 320 W. 10th Avenue, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5179-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891253PMC
July 2016

Genomic diversity of colorectal cancer: Changing landscape and emerging targets.

World J Gastroenterol 2016 Jul;22(25):5668-77

Daniel H Ahn, Tanios Bekaii-Saab, Division of Medical Oncology, Mayo Clinic, Phoenix, AZ 85054, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i25.5668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932204PMC
July 2016

Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.

Clin Colorectal Cancer 2016 Jun 10;15(2):e61-3. Epub 2015 Nov 10.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.10.004DOI Listing
June 2016

Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives.

Gastrointest Cancer 2016 30;6:21-30. Epub 2016 Jun 30.

Department of Medical Oncology, Richard Solove Research Institute and James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/GICTT.S97740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300250PMC
June 2016

Application of next-generation sequencing in gastrointestinal and liver tumors.

Cancer Lett 2016 May 23;374(2):187-91. Epub 2016 Feb 23.

Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, Columbus, OH 43221, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2016.02.029DOI Listing
May 2016

Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer.

Med Oncol 2016 May 11;33(5):48. Epub 2016 Apr 11.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, A445 Starling Loving Hall, 320 W 10th Avenue, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-016-0762-8DOI Listing
May 2016

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

Oncotarget 2016 Feb;7(5):5306-12

Department of Internal Medicine, Divison of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868687PMC
February 2016

Adjuvant therapy for pancreas cancer in an era of value based cancer care.

Cancer Treat Rev 2016 Jan 24;42:10-7. Epub 2015 Nov 24.

The Ohio State University Wexner Medical Center, 310 W. 10th Ave, Columbus, OH, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2015.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976619PMC
January 2016

Biweekly gemcitabine and low-dose cisplatin in the treatment of locally advanced or metastatic pancreatic cancer patients: a single institute experience.

Med Oncol 2016 Jan 22;33(1). Epub 2015 Dec 22.

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, 460 West 10th Ave, C150, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-015-0720-xDOI Listing
January 2016

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

J Natl Cancer Inst 2015 Dec 12;107(12):djv274. Epub 2015 Oct 12.

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (YCT, SKK, ILL, ECH, CSC), Department of Molecular Virology, Immunology, and Medical Genetics (WAH, DCG), Department of Surgery (MB), Department of Internal Medicine (GBL, GM, TBS), and Center for Biostatistics (XM), College of Medicine, and Genomics Shared Resource (DEF, PSY), The Comprehensive Cancer Center, The Ohio State University, Columbus, OH; Institute of Basic Medical Sciences, National Cheng-Kung University, Tainan, Taiwan (CSC); Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan (CSC).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/107/12/djv274.full.pd
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv27
Publisher Site
http://dx.doi.org/10.1093/jnci/djv274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280990PMC
December 2015

Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer.

Oncotarget 2015 Dec;6(42):44509-22

Division of Medical Oncology, Department of Internal Medicine, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/6332
Publisher Site
http://dx.doi.org/10.18632/oncotarget.6332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792572PMC
December 2015

Maintenance therapy for colorectal cancer: which regimen and which patients?

Drugs 2015 Nov;75(16):1833-42

The Ohio State University-James Cancer Hospital and Richard Solove Research Institute, 320 W. 10th Avenue, Columbus, OH, 43221, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-015-0467-xDOI Listing
November 2015

Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary.

Cancer Chemother Pharmacol 2015 Nov 28;76(5):1005-12. Epub 2015 Sep 28.

Richard Solove Research Institute, The Ohio State University Comprehensive Cancer Center-James Cancer Hospital, 320 W 10th Avenue, Columbus, OH, 43221, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2877-6DOI Listing
November 2015

Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.

Oncologist 2015 Oct 2;20(10):1132-9. Epub 2015 Sep 2.

Foundation Medicine, Inc., Cambridge, Massachusetts, USA; Division of Hematology-Oncology, University of California Irvine, Orange, California, USA; The Ohio State University-James Cancer Hospital, Columbus, Ohio, USA; National Translational Research Group, New York, New York, USA; Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591943PMC
October 2015

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer.

Sci Rep 2015 Jul 10;5:12122. Epub 2015 Jul 10.

Divison of Medical Oncology, Ohio State University Comprehensive Cancer Center, 300 W 10th Ave, Columbus, OH 43210.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep12122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894406PMC
July 2015

Rectal Cancer, Version 2.2015.

J Natl Compr Canc Netw 2015 Jun;13(6):719-28; quiz 728

Robert H. Lurie Comprehensive Cancer Center of Northwestern University; UCSF Helen Diller Family Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Vanderbilt-Ingram Cancer Center; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Fred & Pamela Buffett Cancer Center; Mayo Clinic Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Memorial Sloan Kettering Cancer Center; Huntsman Cancer Institute at the University of Utah; Moffitt Cancer Center; University of Michigan Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Duke Cancer Institute; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0087DOI Listing
June 2015